Laman Utama068270 • KRX
add
Celltrion Inc
Tutup sebelumnya
₩176,000.00
Julat hari
₩173,050.00 - ₩176,500.00
Julat tahun
₩144,615.31 - ₩188,800.00
Permodalan pasaran
40.41T KRW
Bilangan Purata
466.80K
Nisbah P/E
70.90
Hasil dividen
0.39%
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 961.46B | 9.91% |
Perbelanjaan pengendalian | 301.28B | 2.01% |
Pendapatan bersih | 61.17B | -21.59% |
Margin untung bersih | 6.36 | -28.70% |
Pendapatan bagi setiap syer | 276.00 | -20.06% |
EBITDA | 319.79B | 56.22% |
Kadar cukai berkesan | -20.74% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 824.00B | -20.06% |
Jumlah aset | 20.55T | 2.10% |
Jumlah liabiliti | 3.89T | 24.20% |
Jumlah ekuiti | 16.66T | — |
Syer tertunggak | 220.28J | — |
Harga kepada buku | 2.35 | — |
Pulangan pada aset | 2.93% | — |
Pulangan pada modal | 3.14% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 61.17B | -21.59% |
Tunai daripada operasi | 188.14B | -35.92% |
Tunai daripada pelaburan | -115.46B | -211.15% |
Tunai daripada pembiayaan | -196.36B | 20.36% |
Perubahan bersih dalam tunai | -178.62B | -213.72% |
Aliran tunai bebas | 92.77B | -9.21% |
Perihal
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Diasaskan
2002
Tapak web
Pekerja
2,680
